schliessen

Filtern

 

Bibliotheken

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
1.
Cover Image

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
by Luabeya, Angelique Kany Kany

Vaccine, 2015, Vol.33 (33), p.4130-4140

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
2.
Cover Image

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
by Penn-Nicholson, Adam

Vaccine, 2015, Vol.33 (32), p.4025-4034

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
3.
Cover Image

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
by Geldenhuys, Hennie

Vaccine, 2015, Vol.33 (30), p.3592-3599

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
4.
Cover Image

H1:IC31 vaccination is safe and induces long-lived TNF-α+ IL-2+ CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial
by Mearns, Helen

Vaccine, 2016, Vol.35 (1), p.132-141

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
5.
Cover Image

Phenotypic variability in childhood TB: Implications for diagnostic endpoints in tuberculosis vaccine trials
by Mulenga, Humphrey

Vaccine, 2011, Vol.29 (26), p.4316-4321

Zum TextVolltext / Suche Add to Book BagAdd to Book Bag
6.
Cover Image

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
by Tameris, Michele D, Dr

The Lancet (British edition), 2013, Vol.381 (9871), p.1021-1028

1

Recommended databases

Find more Articles matching your search terms in these recommended databases.